Barco's clinical application suite for cardiac analysis receives FDA 510(k) clearance
Kortrijk, Belgium, 14 June 2006 - Medical imaging specialist Barco has received 510(k) pre-market clearance from the U.S. Food and Drug Administration for its suite of clinical applications for structural and functional analysis of contrast-enhanced cardiac studies 'CARDIAMETRIX'. CARDIAMETRIX is an option with Barco's flagship software suite for advanced visualization and analysis 'VOXAR 3D'. CARDIAMETRIX is available for integration into PACS with VOXAR 3D and VESSELMETRIX, the company's optional clinical application for quantitative vessel analysis of CTA and MRA.
The VOXAR 3D CARDIAMETRIX suite features integrated clinical applications for coronary artery vessel analysis, calcium scoring, 4D cardiac analysis and left ventricular functional analysis. VOXAR 3D CARDIAMETRIX rapidly evaluates multi-phase studies using up to 6 phases to deliver high-quality visualization of 2D, 3D and 4D images of the heart. It provides an intuitive, productive and clinically effective reading methodology for efficient reading and reporting of cardiac work-ups. All this is achieved through the complete consistency in user interface design applied across the cardiac suite.
"VOXAR 3D CARDIAMETRIX is an exciting addition to the VOXAR 3D product line and provides a suite of powerful tools for radiologists and cardiologists working with 64-slice volumetric cardiac studies. It has been designed to make the task of reading and reporting cardiac studies quick and easy, requiring minimal user intervention and editing," said Calum Cunningham, General Manager of Barco's Voxar Product Group. "The high demand from our PACS partners for integration of VOXAR 3D CARDIAMETRIX into PACS highlights the importance of cardiac imaging," he added.
VOXAR 3D CARDIAMETRIX is also available as an optional clinical application with VOXAR 3D ENTERPRISE. The powerful, off-the-shelf client-server technology and high-performance graphics cards of Voxar 3D Enterprise deliver rapid, enterprise-wide access to volumetric studies, including angiographic and cardiac studies, inside and outside the radiology reading room. This significantly accelerates the speed at which radiologists and cardiologists can load, analyze and communicate cardiac studies throughout the enterprise.
About Barco
Barco, a global technology company headquartered in Kortrijk, Belgium, designs and develops visualization products for a variety of professional markets. Barco has its own facilities for Sales & Marketing, Customer Support, R&D and Manufacturing in Europe, North America and Asia Pacific.
For fiscal year 2005, Barco posted net sales of euro 712.0 million.
Barco's ordinary shares are listed on the Brussels/Euronext stock exchange. Barco is a BEL 20 and a Next 150 company. Share information may be accessed on Bloomberg under the symbol BAR BB and on Reuters under BARBt.BR.
© Copyright 2006 by Barco - May be reproduced by professional press only
For more information, please contact
Koen
Helsen
Marketing director
Medical Imaging Devision
Telephone
+32-56-23 35 79
koen.helsen@barco.com
